Ask The Board

31. Aside From Publications, What Can Academic Scientists Do To Promote Their Research And Discoveries To Potential Licensees Or Drug Developers? 8/1/2022

    See the answer from Chandra Ramanathan, global head of innovation hubs at Danaher Corporation.

32. What Skills Distinguish The More Successful People Working In Healthcare From People Working In Other Sectors? 8/1/2022

    See the answer from Fred Hassan, who is a managing director and partner at Warburg Pincus. As former chairman of Bausch & Lomb and former chairman and CEO of Schering-Plough, he has served on numerous corporate boards, including Amgen, Avon, Pharmacia, Prometheus Biosciences, and Time Warner.

33. What Advice Would You Give To A First Time CEO? 7/1/2022

    See the answer from David Pyott, Board Member, Alnylam Pharmaceuticals.

34. What Are The Most Important Questions To Ask, Or Factors To Consider, When Considering A New Collaboration? 7/1/2022

    See the answer from Axel Hoos, CEO, Scorpion Therapeutics.

35. What Key Elements Should A Company Consider When Setting Up An Expanded-Access Program For An Experimental Drug Candidate? 6/1/2022

    See the answer from Ken Moch, president, Euclidean Life Science Advisors and faculty affiliate at the Division of Medical Ethics at NYU.

36. What Should Biopharma Companies With Drugs Moving Into Phase 3 Clinical Trials Prioritize With Respect To Supporting Payer Access In The U.S.? 6/1/2022

    See the answer from Jeff Berkowitz, CEO, Real Endpoints and Board Member, H. Lundbeck A/S.

37. What Kinds Of Resources And Assistance Can State-Level Industry Trade Associations Offer Start-Up And Early-Stage Biopharmaceutical Companies? 6/1/2022

    See the answer from Stephen Rapundalo, president and CEO, MichBio.

38. How Can Digital Technology Improve The Treatment Of Neurological Disorders? 5/2/2022

    See the answer from John Reynders, VP, R&D strategy, program management, data science at Alexion Pharmaceuticals.

39. How Can I Prepare To Join And Serve On A Board Of Directors? 5/2/2022

    See the answer from Allan Shaw, an independent board member, CalciMedica, consulting CFO, and special advisor.

40. Following The Approval Of Biogen's Aduhelm, There Has Been Talk About “Reining In” The FDA's Accelerated Approval Pathway. How Important Is Accelerated Approval For Rare Disease Drugs? 5/2/2022

    See the answer from John Crowley, chairman and CEO of Amicus Therapeutics.